Author

Björn-Patrick Mohl

Friedrich-Loeffler-Institut

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 1 Organism:multiple species· 1 Assay:proteomics· 1

Frequent Co-Authors

Anne Balkema‐BuschmanniD· 2 shared Antje DickmannsiD· 2 shared Kim M. StegmanniD· 2 shared Matthias DobbelsteiniD· 2 shared Andrew Parker· 1 shared Angele BreithauptiD· 1 shared Asisa VolziD· 1 shared Christian Meyer zu Natrup· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Anne Balkema‐BuschmannORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication

Doha Al Krad, Kim M. Stegmann, Antje Dickmanns, Priya Kumar, Claudia Blaurock, Björn-Patrick Mohl, Sina Jasmin Wille, Angele Breithaupt, Tobias Britzke, Anne Balkema‐Buschmann, Matthias Dobbelstein

This study shows that combining Nirmatrelvir with GRP78 inhibitors strongly reduces SARS-CoV-2 replication in vitro and in a hamster model.

Antiviral Research · Jul 29, 2025Peer-reviewedMicrobiology

Synergistic interference with SARS-CoV-2 replication by Molnupiravir-derived N4 hydroxycytidine and inhibitors of CTP synthetase

Kim M. Stegmann, Antje Dickmanns, Hannah L Fuchs, David Scheibner, Björn-Patrick Mohl, Florian R Moeselaken, Wencke Reineking, Theresa Störk, Asisa Volz, Philip A. Beer, Andrew Parker, Veronika Pilchová, Christian Meyer zu Natrup, Maren von Köckritz-Blickwede, Wolfgang Baumgärtner, , Matthias Dobbelstein

This paper shows that combining N4-hydroxycytidine with CTP synthetase inhibitors strongly reduces SARS-CoV-2 replication in cell culture and animal models.

bioRxiv · Mar 6, 2025 · PreprintMicrobiology